CVS Health (CVS)
(Delayed Data from NYSE)
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$66.63 USD
-0.22 (-0.33%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $66.63 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
A Value D Growth C Momentum B VGM
Zacks News
Factors Likely to Influence Rite Aid's (RAD) Q1 Earnings
by Zacks Equity Research
Strength in PBM and Elixir and expanded omnichannel services are likely to have aided Rite Aid (RAD) in Q1. However, rising pandemic costs and low testing demand are likely to have been worrisome.
CVS Health (CVS) Digital Tools Gain Steam Amid COVID-19 Crisis
by Zacks Equity Research
CVS Health's (CVS) consumer-centric digital strategy is more relevant in the current environment as people are increasingly using technology while staying indoors.
The Zacks Analyst Blog Highlights: Apple, The Home Depot, Sanofi, Applied Materials and CVS Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Apple, The Home Depot, Sanofi, Applied Materials and CVS Health
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $84.23, moving -0.6% from the previous trading session.
Top Stock Reports for Apple, Home Depot & Sanofi
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Apple (AAPL), The Home Depot (HD), and Sanofi (SNY).
Amazon's Physical Pharmacy Not a Grave Threat: 3 Stocks to Buy
by Urmimala Biswas
Investors should not lose optimism and continue to discover the enormous business opportunities this retail pharmacy- drug store industry holds. Here are three stocks, WMT, UNH, HLF, which you can grab now.
CVS Health (CVS) Introduces Changes in ExtraBucks Program
by Zacks Equity Research
CVS Health's (CVS) retail division to offer instant 2% ExtraBucks rewards on purchases through the ExtraCare Rewards loyalty program.
CVS Health (CVS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $84.74 in the latest trading session, marking a -0.77% move from the prior day.
3 Stocks With Telehealth Offerings for Post-Pandemic Gains
by Riya Anand
Stocks like CVS Health (CVS), Walgreens Boots Alliance (WBA) and Allscripts (MDRX) are expected to continue to grow post-pandemic on a series of remote health care product and service launches.
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed at $85.50 in the latest trading session, marking a +0.65% move from the prior day.
Federal Realty (FRT) Boosts Portfolio With Buyouts, Stock Up
by Zacks Equity Research
Federal Realty's (FRT) recent acquisitions offer scope for value creation through redevelopment, merchandising and capital investment.
CVS Health (CVS) Deploys Time-Delay Safes in Georgia Pharmacies
by Zacks Equity Research
CVS Health's (CVS) time-delay safes are anticipated to help reduce robbery incidents.
Here's Why You Should Retain CVS Health (CVS) in Your Portfolio
by Zacks Equity Research
Investors are optimistic about CVS Health (CVS) on solid first-quarter performance and growth in digital health services.
Splunk (SPLK) Q1 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Splunk's (SPLK) first-quarter fiscal 2022 results reflect growth in cloud revenues and customer base expansion despite decline in license revenues.
Why Is CVS Health (CVS) Up 3.6% Since Last Earnings Report?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cigna (CI) Rides on Acquisitions, Strong Capital Deployment
by Zacks Equity Research
Cigna (CI) looks well poised for growth on the back of its acquisitions, membership strength and other growth strategies.
CVS Health (CVS) Launches Clinical Trial Services Business
by Zacks Equity Research
The latest clinical trial experience from CVS Health (CVS) is expected to overcome multiple challenges posed by its current clinical trial model.
CVS Health (CVS) Gains From Digitalization, Hurt by Seasonality
by Zacks Equity Research
CVS Health's (CVS) consumer-centric digital strategy is now more relevant in the current environment as people are using technology while staying indoors.
Top Analyst Reports for Cisco, Sanofi & Charles Schwab
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Cisco Systems, Inc. (CSCO), Sanofi (SNY), and The Charles Schwab Corporation (SCHW).
The Zacks Analyst Blog Highlights: Nike, CVS Health, American Tower Corp, The Southern Co, American International Group and Parker-Hannifin Corp
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nike, CVS Health, American Tower Corp, The Southern Co, American International Group and Parker-Hannifin Corp
Top Stock Reports for Nike, CVS Health & American Tower
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NIKE, Inc. (NKE), CVS Health Corporation (CVS), and American Tower Corporation (AMT).
CVS Health (CVS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
CVS Health (CVS) closed the most recent trading day at $81.12, moving +4.41% from the previous trading session.
CVS Health (CVS) Q1 Earnings Beat Estimates, EPS View Up
by Zacks Equity Research
CVS Health's (CVS) revenues across all the three operating segments improve in Q1. Increased guidance amid the pandemic scenario is another positive.
CVS Health (CVS) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
CVS Health (CVS) delivered earnings and revenue surprises of 18.60% and 0.96%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Wall Street Gears for a Hectic Earnings Week
by Zacks Equity Research
Wall Street Gears for a Hectic Earnings Week.